FindTrial
Sign In

Randomized control trial to assess the effect of peanut intake daily for 16 weeks on cardio metabolic risk reduction.

Effect of peanuts on glycemic control, cardiometabolic risk, and general wellness (cognition, sleep quality, mood) among Asian Indians with overweight and obesity - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060479
Enrollment
210
Registered
2023-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Intervention group-60g peanut for 16 weeks: Standard Indian diet (adjusted for caloric intake) with daily 60g of roasted peanuts for 16 week periods. Control Intervention1: Control grou

Sponsors

Madras Diabetes Research Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants who are overweight and obese Age group 30 to 65 yrs, both males and females Willing to follow study protocol Willing to give informed consent

Exclusion criteria

Exclusion criteria: BMI less than 22.9 kg/m2 On insulin injections Any acute infections like viral fever, typhoid, cold, diarrhea, constipation last 1 month Having diabetes, diabetes induced/related complications [nephropathy, retinopathy]- thyroid dysfunction, respiratory disorders, cancer or heart attack and stroke, Having any eating disorder or lactose intolerance Taking any herbal/Ayurvedic/traditional preparation/nutrition supplements that could profoundly affect blood glucose Pregnant and lactating Women Plans to relocate in the next 2 years. Planning longer duration of travel out of town Enrolled in any other clinical trials Participated in a clinical study in the last 3 months Employee of the site conducting the study. Participants with habitual abuse (Alcohol, smoking, tobacco) substance consumption

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of peanut administered for 16 weeks on markers of glycemic- HbA1c, fasting and post glucose, dyslipidemia-total cholesterol, HDL,LDL and triglyceride levels, body composition-weight, body mass index and waist circumference and inflammatory markers as compared to control group.Timepoint: Blood samples will be collected at 2 time points baseline and end of 16 weeks study period. Inaddition participant will be contacted by the research team monthly once for anthropometric, clinical and dietary assessments.—

Secondary

MeasureTime frame
Examine peanut supplementation will have beneficial effects on measures of cognition, sleep quality & mood as compared to control group.Timepoint: 2 time points baseline & end of 16 weeks study period.—

Countries

India

Contacts

Public ContactMrs Sudha Vasudevan

Madras Diabetes Research Foundation

dranjana@drmohans.com044439688888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026